Total Payments
$188.14
2024 Payments
$47.16
Companies
4
Transactions
19
Medicare Patients
7,880
Medicare Billing
$827,781
Payment Breakdown by Category
Education$127.84 (67.9%)
Food & Beverage$60.30 (32.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $127.84 | 16 | 67.9% |
| Food and Beverage | $60.30 | 3 | 32.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $127.84 | 16 | $0 (2017) |
| Vanda Pharmaceuticals Inc. | $25.66 | 1 | $0 (2024) |
| ABBVIE INC. | $21.50 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $13.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.16 | 2 | Vanda Pharmaceuticals Inc. ($25.66) |
| 2017 | $140.98 | 17 | PFIZER INC. ($127.84) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/26/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/12/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $5.30 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/30/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/09/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/18/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/28/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/17/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/17/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $5.30 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/10/2017 | PFIZER INC. | ELIQUIS (Drug) | Education | In-kind items and services | $8.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/10/2017 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $5.30 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,715 | 2,213 | $616,884 | $198,102 |
| 2022 | 20 | 1,892 | 2,578 | $638,131 | $205,869 |
| 2021 | 25 | 2,331 | 3,098 | $708,745 | $248,374 |
| 2020 | 18 | 1,942 | 2,577 | $581,661 | $175,437 |
Total Patients
7,880
Total Services
10,466
Medicare Billing
$827,781
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 486 | 812 | $258,313 | $74,492 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 446 | 446 | $136,271 | $59,911 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 270 | 347 | $78,044 | $19,588 | 25.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 62 | 70 | $34,241 | $11,894 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 56 | $24,896 | $7,855 | 31.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $13,406 | $5,653 | 42.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 18 | $11,630 | $4,142 | 35.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 67 | 94 | $33,138 | $4,094 | 12.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $9,198 | $3,606 | 39.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 26 | 26 | $4,373 | $1,971 | 45.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 45 | 49 | $4,560 | $1,636 | 35.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $2,415 | $1,007 | 41.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $1,509 | $629.40 | 41.7% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 32 | 34 | $1,300 | $385.11 | 29.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,131 | $288.96 | 25.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 26 | $198.64 | $194.74 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 12 | 13 | $492.70 | $170.56 | 34.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 11 | 19 | $534.09 | $157.51 | 29.5% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 11 | 17 | $255.00 | $88.23 | 34.6% |
| 84075 | Phosphatase (enzyme) level, alkaline | Office | 2023 | 11 | 17 | $249.05 | $86.36 | 34.7% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 11 | 17 | $249.05 | $86.36 | 34.7% |
| 82247 | Bilirubin level, total | Office | 2023 | 11 | 17 | $241.23 | $83.64 | 34.7% |
| 82040 | Albumin (protein) level | Office | 2023 | 11 | 17 | $238.17 | $82.45 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 576 | 1,065 | $314,137 | $93,332 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 490 | 490 | $149,715 | $66,524 | 44.4% |
About Dr. Miguel Prieto, MD
Dr. Miguel Prieto, MD is a Integrative Medicine healthcare provider based in Bourne, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437144847.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miguel Prieto, MD has received a total of $188.14 in payments from pharmaceutical and medical device companies, with $47.16 received in 2024. These payments were reported across 19 transactions from 4 companies. The most common payment nature is "Education" ($127.84).
As a Medicare-enrolled provider, Prieto has provided services to 7,880 Medicare beneficiaries, totaling 10,466 services with total Medicare billing of $827,781. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Integrative Medicine
- Other Specialties Internal Medicine, Internal Medicine
- Location Bourne, MA
- Active Since 09/13/2005
- Last Updated 04/28/2025
- Taxonomy Code 202D00000X
- Entity Type Individual
- NPI Number 1437144847
Products in Payments
- ELIQUIS (Drug) $96.14
- CHANTIX (Drug) $31.70
- PONVORY (Drug) $25.66
- VRAYLAR (Drug) $21.50
- INVOKANA (Drug) $13.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.